XML 25 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:      
Net income $ 2,748.8 $ 527.8 $ 350.0
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 635.6 437.2 171.6
Impairment of goodwill, intangibles and other assets 85.0    
Net gain from sale of businesses (713.0) (161.1) (154.2)
Loss on extinguishment of debt (1.9) 47.6  
Non-cash restructuring charges   23.7 6.7
Deferred income taxes (1,781.8) 33.4 (7.2)
Stock-based compensation expense 70.9 63.9 29.2
Pension settlement charge (gain) (2.4) 2.7 52.1
Venezuela deconsolidation charge     172.7
Other, net 11.0 21.0 32.5
Changes in operating assets and liabilities, excluding the effects of acquisitions and divestitures:      
Accounts receivable 288.7 (324.5) (33.8)
Inventories (350.4) 784.6 (97.8)
Accounts payable 211.0 282.0 20.3
Accrued liabilities and other (269.5) 102.1 50.8
Net cash provided by operating activities 932.0 1,840.4 592.9
Cash flows from investing activities:      
Proceeds from sale of divested businesses 2,106.9 227.2 214.8
Acquisitions and acquisition-related activity (634.3) (8,635.2) (573.7)
Capital expenditures (406.2) (441.4) (211.4)
Cash related to deconsolidation of Venezuela operations     (97.5)
Other investing activities 12.1 24.6 17.9
Net cash provided by (used in) investing activities 1,078.5 (8,824.8) (649.9)
Cash flows from financing activities:      
Net short-term debt 111.8 (641.4) (57.0)
Proceeds from issuance of debt, net of debt issuance costs   9,414.6 594.6
Payments on long-term debt (1,512.2) (1,100.0)  
Repurchase of shares of common stock (152.4)   (180.4)
Cash dividends (428.6) (328.6) (206.3)
Payments to dissenting shareholders (161.6)    
Repurchase of restricted shares for vesting, net of option proceeds (18.6) (16.1) (5.7)
Net cash provided by (used in) financing activities (2,161.6) 7,328.5 145.2
Exchange rate effect on cash and cash equivalents 49.3 (31.4) (12.8)
Increase (decrease) in cash and cash equivalents (101.8) 312.7 75.4
Cash and cash equivalents at beginning of period 587.5 274.8 199.4
Cash and cash equivalents at end of period 485.7 587.5 274.8
Supplemental non-cash disclosures:      
Common stock issued for Jarden Acquisition   9,480.3  
Debt assumed, at fair value, in the Jarden Acquisition   1,198.7  
Supplemental disclosures - cash paid for:      
Income taxes, net of refunds 261.8 189.2 54.7
Interest $ 459.4 $ 316.0 $ 82.9